Tıbbi Onkoloji Bilim Dalı
aguvenmert[at]baskent.edu.tr
0(312) 246 66 66
H-İndeks
7
• Tıbbi Onkoloji (İç Hastalıkları)
Yayın Bilgileri
1
Low Skeletal Muscle Mass as a Proxy Marker of Sarcopenia is a Risk Factor for Major Complications in Older Patients Undergoing Curative Colon Resections for Colon Cancer, Frontiers in Medicine, 1464978(0), 2025
Öğr.Gör. İsmail Tirnova, Maya Gasimova, Çağla Sarıtürk, Prof. Dr. Hatice Akay, Öğr.Gör. Aslihan Güven Mert, Öğr.Gör. Özlem Yenidünya, Prof. Dr. Feza Yarbuğ Karakayali |
|
2
Definitive chemoradiotherapy versus upfront surgery in locoregional esophageal squamous cell cancer, Annals of Medical Research, 31(11), 2024
Nurhan Önal Kalkan, Öğr.Gör. Aslihan Güven Mert, Umut Çakıroğlu, Mehmet Naci Aldemir, Çetin Kotan |
|
3
The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases, EJSO, 46(3), 2020
Oktar Asoglu; , Handan Tokmak, Baris Bakir;, Gokhan Demir , Banu Atalar; , Süha Göksel, Burak Koza, Öğr.Gör. Aslihan Güven Mert, Atakan Demir, Koray Güven |
|
4
Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?, Journal of BUON, 25(3), 2020
Atakan Demir, Özkan Alan, Öğr.Gör. Aslihan Güven Mert, Sinan Koca |
|
5
New horizons from novel therapies in malignant pleural mesothelioma, Advances in Respiratory Medicine, 88(4), 2020
Mutlay Sayan, Swati Mamidanna, Mehmet Fuat , Vasudev Daliparty, Teuta Zoto Mustafayev, Carl Nelson, Nisha Ohri , Salma K. Jabour, Öğr.Gör. Aslihan Güven Mert, Banu Atalar |
|
6
Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group, Turkish Journal of Gastroenterology, 30(7), 2019
İstanbul Group, Öğr.Gör. Aslihan Güven Mert |
|
7
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients, TUMOR BIOLOGY, 37(7), 2016
Melike Özçelik, Taner Korkmaz, Hatice Odabaş, Cengiz Gemici, Özlem Ercelep, Sinemis Yüksel, Öğr.Gör. Aslihan Güven Mert, Heves Sürmeli, Deniz Işık, Kübra Aydın |
|
8
The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients, Clinical & Translational Oncology, 18(6), 2016
Melike Özçelik, Hatice Odabaş, Özlem Ercelep, Sinemis Yüksel, Öğr.Gör. Aslihan Güven Mert |
|
9
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer, Oncology Research and Treatment, 39(3), 2016
Nur Şener Dinç, Kübra Aydın, Hatice Odabaş, Özlem Ercelep, Gülnihal Tufan, Mesut Şeker, Nurgül Yaşar, Dinçer Aydın, Sinemis Yüksel, Öğr.Gör. Aslihan Güven Mert |
|
10
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy, Clinical & Translational Oncology, 17(8), 2015
Dinçer Aydın, Ahmet Bilici, Deniz Yavuzer, Umut Kefeli, Ahmet Tan, Özlem Ercelep, Öğr.Gör. Aslihan Güven Mert |
|
11
THREE DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER, ANNALS OF ONCOLOGY, 25(4), 2014
Melike Özçelik, Özlem Ercelep, Öğr.Gör. Aslihan Güven Mert, Sinemis Yüksel, P Özdemir |
|
12
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis, Clinical & Translational Oncology, 15(7), 2013
Taner Korkmaz, Selçuk Şeber, Ebru Sarı, M Canhoroz, Başak Öven, Emre Yıldırım, Nurgül Yaşar, Dinçer Aydın, Özlem Ercelep Balvan, Sinemis Yüksel, Öğr.Gör. Aslihan Güven Mert |
|
13
The relationship between collapsin response mediator protein-1 (CRMP 1) expression and histopathogic parameters and survival in patient with gastric cancer., JOURNAL OF CLINICAL ONCOLOGY, 31(15), 2013
Mahmut Gümüş, Nurgül Yaşar, Sibel Kayahan, Sinemis Yüksel, Özlem Ercelep, Öğr.Gör. Aslihan Güven Mert, Nur Dinç, Dinçer Aydın, Kübra Aydın |
|
14
The relationship between tumor markers and histopathologic and demographic features of patients with breast cancer and their distinctive role in metastatic process., JOURNAL OF CLINICAL ONCOLOGY, 31(15), 2013
Kübra Aydın, Meliha Melin Uğur, Hatice Odabaş, Taner Korkmaz, Nurgül Yaşar, Nur Dinç, Dinçer Aydın, Sinemis Yüksel, Öğr.Gör. Aslihan Güven Mert, Özlem Ercelep Balvan |
|
15
Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology), ONCOLOGY, 83(3), 2012
Muhammet Ali Kaplan, Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Özge Gümüşay, Ramazan Yıldız, Lütfiye Demir, Çağlayan Geredeli, Adem Dayan, Murat Koçer, Ulkü Yalçıntaş, Ali İnal, Olçun Ümit Ünal, Öğr.Gör. Aslihan Güven Mert, Mehmet Bilici, Metin Özkan |
|
16
Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment, BIOMARKERS, 17(7), 2012
Umut Kefeli, Mahmut Emre Yıldırım, Dinçer Aydın, Özlem Çakır Madenci, Nurgül Yaşar, Nur Şener, Öğr.Gör. Aslihan Güven Mert, Sinemis Yüksel, Özlem Ercelep |
|
17
Efficacy, safety and prognostic features of resected colon carcinoma treated in ``real world{''} practice: a retrospective cohort-study, Journal of BUON, 16(2), 2011
Faysal Dane, Ehmet Akif Öztürk, Mahmut Gümüş, Öğr.Gör. Aslihan Güven Mert, Mehmet Ali Ustaoğlu, Devrim Çabuk, Mehmet Teomete |
|
18
Precursor B cell lymphoblastic lymphoma presenting as a solitary bone tumor: a case report and review of the literature, INTERNATIONAL JOURNAL OF HEMATOLOGY, 92(5), 2010
Işık Kaygusuz, Tayfur Toptaş, Öğr.Gör. Aslihan Güven Mert, Tülin Fıratlı Tuğlular, Tülay Tecimer, Mahmut Bayık |
BAŞKENT ÜNİVERSİTESİ